CN107898819A - 一种隐形眼镜保湿润眼液 - Google Patents
一种隐形眼镜保湿润眼液 Download PDFInfo
- Publication number
- CN107898819A CN107898819A CN201711033533.XA CN201711033533A CN107898819A CN 107898819 A CN107898819 A CN 107898819A CN 201711033533 A CN201711033533 A CN 201711033533A CN 107898819 A CN107898819 A CN 107898819A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- moisturizing
- visual function
- improving liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 16
- 230000004382 visual function Effects 0.000 title claims abstract description 16
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 15
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 16
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000013589 supplement Substances 0.000 claims abstract description 13
- 239000011782 vitamin Substances 0.000 claims abstract description 13
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000008367 deionised water Substances 0.000 claims abstract description 8
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 8
- 239000000686 essence Substances 0.000 claims abstract description 8
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 229960003080 taurine Drugs 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- -1 sorbitol ester Chemical class 0.000 claims abstract description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 6
- 239000001509 sodium citrate Substances 0.000 claims abstract description 6
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 6
- 239000000600 sorbitol Substances 0.000 claims abstract description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 20
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 10
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 10
- 229930003451 Vitamin B1 Natural products 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 10
- 229960003495 thiamine Drugs 0.000 claims description 10
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 10
- 235000019155 vitamin A Nutrition 0.000 claims description 10
- 239000011719 vitamin A Substances 0.000 claims description 10
- 235000010374 vitamin B1 Nutrition 0.000 claims description 10
- 239000011691 vitamin B1 Substances 0.000 claims description 10
- 235000019158 vitamin B6 Nutrition 0.000 claims description 10
- 239000011726 vitamin B6 Substances 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 229940045997 vitamin a Drugs 0.000 claims description 10
- 229940011671 vitamin b6 Drugs 0.000 claims description 10
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 7
- 235000013734 beta-carotene Nutrition 0.000 claims description 7
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 7
- 239000011648 beta-carotene Substances 0.000 claims description 7
- 229960002747 betacarotene Drugs 0.000 claims description 7
- VKJKEPKFPUWCAS-UHFFFAOYSA-M potassium chlorate Chemical compound [K+].[O-]Cl(=O)=O VKJKEPKFPUWCAS-UHFFFAOYSA-M 0.000 claims description 7
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 7
- 206010013774 Dry eye Diseases 0.000 abstract description 4
- 208000003464 asthenopia Diseases 0.000 abstract description 4
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract description 2
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 201000009487 Amblyopia Diseases 0.000 description 1
- 101100203924 Caenorhabditis elegans sorb-1 gene Chemical group 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Ophthalmology & Optometry (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种隐形眼镜保湿润眼液,其原料包括以下重量份组分:葛根素2‑3份、杭菊原素1‑2份、β‑胡萝卜素1‑2份、门冬氯酸钾0.5‑1份、维生素添加剂1‑1.5份、牛磺酸0.5‑1份、枸橼酸钠1‑3份、山梨醇酯1‑2份、珍珠液5‑10份、去离子水30‑40份。本发明的润眼液具有缓解眼部疲劳、酸痛、抗辐射、保湿以及缓解眼部干燥、消除炎症和抑菌的能力,对长时间佩戴隐形眼镜引起的眼部视觉疲劳、眼干眼涩等症状具有一定功效。
Description
技术领域
本发明属于眼睛保健技术领域,具体涉及一种隐形眼镜保湿润眼液。
背景技术
随着现代文化生活节奏的加快,工作、学习过度紧张,心理素质负担过重,加之生态环境的不洁污染、如空气尘埃、烟雾等空气质量的影响及自身精神紧张,劳逸协调不当,长期用眼过度,眼睛得不到充分的调养和休息,同时诸多因素诱发的眼睛病变越来越多,不同程度的病变可致眼视力下降,形成近视、弱视等,因为佩戴眼镜影响美观,越来越多的人选择佩戴隐形眼镜,但隐形眼镜在佩戴过程中,由于时间长或气候干燥等,眼睛容易疲劳、干燥等。
发明内容
针对上述,本发明的目的是提供一种隐形眼镜专用保湿润眼液。
本发明采取的技术方案是:
一种隐形眼镜保湿润眼液,其原料包括以下重量份组分:葛根素 2-3份、杭菊原素1-2份、β-胡萝卜素1-2份、门冬氯酸钾0.5-1 份、维生素添加剂1-1.5份、牛磺酸0.5-1份、枸橼酸钠1-3份、山梨醇酯1-2份、珍珠液5-10份、去离子水30-40份。
优选地,所述的隐形眼镜保湿润眼液,其原料包括以下重量份组分:葛根素2.5份、杭菊原素1.5份、β-胡萝卜素1.5份、门冬氯酸钾0.75份、维生素添加剂1.25份、牛磺酸0.75份、枸橼酸钠2 份、山梨醇酯1.5份、珍珠液7.5份、去离子水35份。
进一步地,所述的维生素添加剂包括维生素A、维生素B1、维生素B6、维生素E。
优选地,所述的维生素A、维生素B1、维生素B6、维生素E 重量配比为2:0.5:1:2-3。
本发明的有益效果是:本发明的润眼液具有缓解眼部疲劳、酸痛、抗辐射、保湿以及缓解眼部干燥、消除炎症和抑菌的能力,对长时间佩戴隐形眼镜引起的眼部视觉疲劳、眼干眼涩等症状具有一定功效。
具体实施方式
下面对本发明的较佳实施例进行详细阐述,以使本发明的优点和特征能更易于被本领域技术人员理解,从而对本发明的保护范围做出更为清楚明确的界定。
实施例1
一种隐形眼镜保湿润眼液,其原料包括以下重量份组分:葛根素 2份、杭菊原素1份、β-胡萝卜素1份、门冬氯酸钾0.5份、维生素添加剂1份、牛磺酸0.5份、枸橼酸钠1份、山梨醇酯1份、珍珠液5份、去离子水30份。
所述的维生素添加剂包括维生素A、维生素B1、维生素B6、维生素E,所述的维生素A、维生素B1、维生素B6、维生素E重量配比为2:0.5:1:2。
实施例2
一种隐形眼镜保湿润眼液,其原料包括以下重量份组分:葛根素2.5份、杭菊原素1.5份、β-胡萝卜素1.5份、门冬氯酸钾0.75份、维生素添加剂1.25份、牛磺酸0.75份、枸橼酸钠2份、山梨醇酯 1.5份、珍珠液7.5份、去离子水35份。
所述的维生素添加剂包括维生素A、维生素B1、维生素B6、维生素E,所述的维生素A、维生素B1、维生素B6、维生素E重量配比为2:0.5:1:2.5。
实施例3
一种隐形眼镜保湿润眼液,其原料包括以下重量份组分:葛根素 3份、杭菊原素2份、β-胡萝卜素2份、门冬氯酸钾1份、维生素添加剂1.5份、牛磺酸1份、枸橼酸钠3份、山梨醇酯2份、珍珠液 10份、去离子水40份。
所述的维生素添加剂包括维生素A、维生素B1、维生素B6、维生素E,所述的维生素A、维生素B1、维生素B6、维生素E重量配比为2:0.5:1:3。
Claims (4)
1.一种隐形眼镜保湿润眼液,其特征在于其原料包括以下重量份组分:葛根素2-3份、杭菊原素1-2份、β-胡萝卜素1-2份、门冬氯酸钾0.5-1份、维生素添加剂1-1.5份、牛磺酸0.5-1份、枸橼酸钠1-3份、山梨醇酯1-2份、珍珠液5-10份、去离子水30-40份。
2.根据权利要求1所述的隐形眼镜保湿润眼液,其特征在于其原料包括以下重量份组分:葛根素2.5份、杭菊原素1.5份、β-胡萝卜素1.5份、门冬氯酸钾0.75份、维生素添加剂1.25份、牛磺酸0.75份、枸橼酸钠2份、山梨醇酯1.5份、珍珠液7.5份、去离子水35份。
3.根据权利要求1所述的隐形眼镜保湿润眼液,其特征在于所述的维生素添加剂包括维生素A、维生素B1、维生素B6、维生素E。
4.根据权利要求3所述的隐形眼镜保湿润眼液,其特征在于所述的维生素A、维生素B1、维生素B6、维生素E重量配比为2:0.5:1:2-3。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711033533.XA CN107898819A (zh) | 2017-10-30 | 2017-10-30 | 一种隐形眼镜保湿润眼液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711033533.XA CN107898819A (zh) | 2017-10-30 | 2017-10-30 | 一种隐形眼镜保湿润眼液 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107898819A true CN107898819A (zh) | 2018-04-13 |
Family
ID=61842895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711033533.XA Pending CN107898819A (zh) | 2017-10-30 | 2017-10-30 | 一种隐形眼镜保湿润眼液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107898819A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102185562B1 (ko) * | 2019-06-10 | 2020-12-02 | 인제대학교 산학협력단 | 베타-카로틴을 포함하는 청색광 차단용 콘텍트 렌즈 조성물 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1395959A (zh) * | 2002-08-14 | 2003-02-12 | 庄景云 | 眼必静眼药水 |
CN104586883A (zh) * | 2014-12-31 | 2015-05-06 | 李艳琼 | 一种可以治疗近视的眼药水 |
CN105663160A (zh) * | 2016-04-14 | 2016-06-15 | 齐齐哈尔市前进医药有限责任公司 | 一种眼元素滴眼液及其制备方法 |
-
2017
- 2017-10-30 CN CN201711033533.XA patent/CN107898819A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1395959A (zh) * | 2002-08-14 | 2003-02-12 | 庄景云 | 眼必静眼药水 |
CN104586883A (zh) * | 2014-12-31 | 2015-05-06 | 李艳琼 | 一种可以治疗近视的眼药水 |
CN105663160A (zh) * | 2016-04-14 | 2016-06-15 | 齐齐哈尔市前进医药有限责任公司 | 一种眼元素滴眼液及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102185562B1 (ko) * | 2019-06-10 | 2020-12-02 | 인제대학교 산학협력단 | 베타-카로틴을 포함하는 청색광 차단용 콘텍트 렌즈 조성물 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107802561A (zh) | 一种护理眼部凝胶及其生产方法 | |
CN104586741B (zh) | 一种泡泡酵素面膜 | |
CN109908199A (zh) | 一种洋甘菊洗眼液 | |
CN111467274A (zh) | 一种快速祛皱祛眼袋的眼霜 | |
CN102851958A (zh) | 一种织物抗紫外线处理剂 | |
CN107898819A (zh) | 一种隐形眼镜保湿润眼液 | |
CN104116668A (zh) | 一种美白精油 | |
CN103720615A (zh) | 一种温和洗面奶 | |
CN109908198A (zh) | 一种矢车菊洗眼液 | |
CN106822604A (zh) | 一种用于眼部保健的外用中药组合物及其制备方法 | |
CN103284903B (zh) | 乙烯月桂酸酯液态护肤品的制备方法 | |
CN106551882A (zh) | 一种抗过敏的保湿柔肤水 | |
CN108030708A (zh) | 一种美白面膜 | |
CN102973427A (zh) | 薄荷沐浴露 | |
CN114246814A (zh) | 酵素眼部护理液 | |
CN102961314A (zh) | 一种蜂胶唇部去角质软膏 | |
CN104546629A (zh) | 一种补水美白眼霜 | |
CN203616538U (zh) | 一种纳米眼镜 | |
CN102318701A (zh) | 一种明目保健茶 | |
CN104116669A (zh) | 一种美眼精油 | |
CN104666229A (zh) | 一种护理眼部肌肤的天然美容液 | |
CN106551949A (zh) | 隐形眼镜润滑滴眼液 | |
CN201508441U (zh) | 微能镜 | |
CN201876630U (zh) | 多功能眼镜 | |
CN202589876U (zh) | 视功能综合训练仪 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180413 |